seed
Stage
1
Investors
About
Oncocidia Ltd is developing a targeted radiopharmaceutical cancer treatment called Oncocidia, focused on delivering radionuclide therapy selectively to cancer cells. The company is developing this targeted therapeutic approach for oncology applications.
Explore Oncocidia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.